Systematic review on role of structure based drug design (SBDD) in the identification of anti-viral leads against SARS-Cov-2
The outbreak of existing public health distress is threatening the entire world with emergence and rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The novel coronavirus disease 2019 (COVID-19) is mild in most people. However, in some elderly people with co-morbid condit...
Saved in:
Main Authors: | Nilesh Gajanan Bajad (Author), Swetha Rayala (Author), Gopichand Gutti (Author), Anjali Sharma (Author), Meenakshi Singh (Author), Ashok Kumar (Author), Sushil Kumar Singh (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Indole: A promising scaffold for the discovery and development of potential anti-tubercular agents
by: Nilesh Gajanan Bajad, et al.
Published: (2022) -
Computational guided identification of potential leads from Acacia pennata (L.) Willd. as inhibitors for cellular entry and viral replication of SARS-CoV-2
by: James H. Zothantluanga, et al.
Published: (2021) -
Targeting Viral Ion Channels: A Promising Strategy to Curb SARS-CoV-2
by: Anamika Singh, et al.
Published: (2022) -
Rate of shed of SARS COV-2 viral RNA from COVID-19 cadavers
by: Meenakshi Sharma, et al.
Published: (2022) -
Waning natural and vaccine-induced immunity leading to reinfection with SARS-CoV-2 Omicron variant
by: Anita M. Shete, et al.
Published: (2022)